MS functional composite: relation to disease phenotype and disability strata

N.F. Kalkers, V. de Groot, R.H.C. Lazeron, J. Killestein, H.J. Adèr, F. Barkhof, G.J. Lankhorst, C.H. Polman

Research output: Contribution to journalArticleAcademicpeer-review

84 Citations (Scopus)

Abstract

Objective: The MS Functional Composite (MSFC), a recently developed outcome measure for clinical trials, was applied to 240 patients with MS to explore its utility in different subgroups of MS and for comparison with the Expanded Disability Status Scale (EDSS). Method: Three clinical dimensions were examined: arm/hand function, leg function/ambulation, and cognition. Predictions of relative scores on the MSFC and its components in three major MS phenotypes (relapsing-remitting, primary progressive, and secondary progressive) and three strata of disability were developed and tested. Also, correlations with EDSS were calculated and the effect of an external reference population was assessed. Results: Mean MSFC score was positive in the relapsing-remitting (0.4) and mildly disabled (0.4) groups and negative in the secondary progressive (-0.3), primary progressive (-0.4), and moderately (-0.07) and severely disabled (-1.0) groups. The correlation between EDSS and MSFC was strong (-0.68). EDSS correlated strongly with ambulation in secondary and primary progressive patients and severely disabled patients, moderately with arm/hand function for all analyzed groups, and not at all with cognition. Comparison with an external reference population showed changes in MSFC- and Z-scores, but did not result in altered differences between the subgroups. Conclusion: Our prospective study in subgroups of MS confirmed and extended the construct validity of the MSFC. The MSFC also showed good concurrent validity with the EDSS, and includes information about cognition.

Original languageEnglish
Pages (from-to)1233-1239
Number of pages7
JournalNeurology
Volume54
Issue number6
Publication statusPublished - 28 Mar 2000
Externally publishedYes

Fingerprint

Cognition
Phenotype
Walking
Arm
Hand
Population
Leg
Outcome Assessment (Health Care)
Clinical Trials
Prospective Studies

Keywords

  • Expanded Disability Status Scale
  • MS
  • MS Functional Composite

Cite this

Kalkers, N. F., de Groot, V., Lazeron, R. H. C., Killestein, J., Adèr, H. J., Barkhof, F., ... Polman, C. H. (2000). MS functional composite: relation to disease phenotype and disability strata. Neurology, 54(6), 1233-1239.
Kalkers, N.F. ; de Groot, V. ; Lazeron, R.H.C. ; Killestein, J. ; Adèr, H.J. ; Barkhof, F. ; Lankhorst, G.J. ; Polman, C.H. / MS functional composite: relation to disease phenotype and disability strata. In: Neurology. 2000 ; Vol. 54, No. 6. pp. 1233-1239.
@article{0613d31246b949179ae0fc3a5a5fefb0,
title = "MS functional composite: relation to disease phenotype and disability strata",
abstract = "Objective: The MS Functional Composite (MSFC), a recently developed outcome measure for clinical trials, was applied to 240 patients with MS to explore its utility in different subgroups of MS and for comparison with the Expanded Disability Status Scale (EDSS). Method: Three clinical dimensions were examined: arm/hand function, leg function/ambulation, and cognition. Predictions of relative scores on the MSFC and its components in three major MS phenotypes (relapsing-remitting, primary progressive, and secondary progressive) and three strata of disability were developed and tested. Also, correlations with EDSS were calculated and the effect of an external reference population was assessed. Results: Mean MSFC score was positive in the relapsing-remitting (0.4) and mildly disabled (0.4) groups and negative in the secondary progressive (-0.3), primary progressive (-0.4), and moderately (-0.07) and severely disabled (-1.0) groups. The correlation between EDSS and MSFC was strong (-0.68). EDSS correlated strongly with ambulation in secondary and primary progressive patients and severely disabled patients, moderately with arm/hand function for all analyzed groups, and not at all with cognition. Comparison with an external reference population showed changes in MSFC- and Z-scores, but did not result in altered differences between the subgroups. Conclusion: Our prospective study in subgroups of MS confirmed and extended the construct validity of the MSFC. The MSFC also showed good concurrent validity with the EDSS, and includes information about cognition.",
keywords = "Expanded Disability Status Scale, MS, MS Functional Composite",
author = "N.F. Kalkers and {de Groot}, V. and R.H.C. Lazeron and J. Killestein and H.J. Ad{\`e}r and F. Barkhof and G.J. Lankhorst and C.H. Polman",
year = "2000",
month = "3",
day = "28",
language = "English",
volume = "54",
pages = "1233--1239",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "6",

}

Kalkers, NF, de Groot, V, Lazeron, RHC, Killestein, J, Adèr, HJ, Barkhof, F, Lankhorst, GJ & Polman, CH 2000, 'MS functional composite: relation to disease phenotype and disability strata', Neurology, vol. 54, no. 6, pp. 1233-1239.

MS functional composite: relation to disease phenotype and disability strata. / Kalkers, N.F.; de Groot, V.; Lazeron, R.H.C.; Killestein, J.; Adèr, H.J.; Barkhof, F.; Lankhorst, G.J.; Polman, C.H.

In: Neurology, Vol. 54, No. 6, 28.03.2000, p. 1233-1239.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - MS functional composite: relation to disease phenotype and disability strata

AU - Kalkers, N.F.

AU - de Groot, V.

AU - Lazeron, R.H.C.

AU - Killestein, J.

AU - Adèr, H.J.

AU - Barkhof, F.

AU - Lankhorst, G.J.

AU - Polman, C.H.

PY - 2000/3/28

Y1 - 2000/3/28

N2 - Objective: The MS Functional Composite (MSFC), a recently developed outcome measure for clinical trials, was applied to 240 patients with MS to explore its utility in different subgroups of MS and for comparison with the Expanded Disability Status Scale (EDSS). Method: Three clinical dimensions were examined: arm/hand function, leg function/ambulation, and cognition. Predictions of relative scores on the MSFC and its components in three major MS phenotypes (relapsing-remitting, primary progressive, and secondary progressive) and three strata of disability were developed and tested. Also, correlations with EDSS were calculated and the effect of an external reference population was assessed. Results: Mean MSFC score was positive in the relapsing-remitting (0.4) and mildly disabled (0.4) groups and negative in the secondary progressive (-0.3), primary progressive (-0.4), and moderately (-0.07) and severely disabled (-1.0) groups. The correlation between EDSS and MSFC was strong (-0.68). EDSS correlated strongly with ambulation in secondary and primary progressive patients and severely disabled patients, moderately with arm/hand function for all analyzed groups, and not at all with cognition. Comparison with an external reference population showed changes in MSFC- and Z-scores, but did not result in altered differences between the subgroups. Conclusion: Our prospective study in subgroups of MS confirmed and extended the construct validity of the MSFC. The MSFC also showed good concurrent validity with the EDSS, and includes information about cognition.

AB - Objective: The MS Functional Composite (MSFC), a recently developed outcome measure for clinical trials, was applied to 240 patients with MS to explore its utility in different subgroups of MS and for comparison with the Expanded Disability Status Scale (EDSS). Method: Three clinical dimensions were examined: arm/hand function, leg function/ambulation, and cognition. Predictions of relative scores on the MSFC and its components in three major MS phenotypes (relapsing-remitting, primary progressive, and secondary progressive) and three strata of disability were developed and tested. Also, correlations with EDSS were calculated and the effect of an external reference population was assessed. Results: Mean MSFC score was positive in the relapsing-remitting (0.4) and mildly disabled (0.4) groups and negative in the secondary progressive (-0.3), primary progressive (-0.4), and moderately (-0.07) and severely disabled (-1.0) groups. The correlation between EDSS and MSFC was strong (-0.68). EDSS correlated strongly with ambulation in secondary and primary progressive patients and severely disabled patients, moderately with arm/hand function for all analyzed groups, and not at all with cognition. Comparison with an external reference population showed changes in MSFC- and Z-scores, but did not result in altered differences between the subgroups. Conclusion: Our prospective study in subgroups of MS confirmed and extended the construct validity of the MSFC. The MSFC also showed good concurrent validity with the EDSS, and includes information about cognition.

KW - Expanded Disability Status Scale

KW - MS

KW - MS Functional Composite

UR - http://www.scopus.com/inward/record.url?scp=0034724163&partnerID=8YFLogxK

M3 - Article

C2 - 10746590

AN - SCOPUS:0034724163

VL - 54

SP - 1233

EP - 1239

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 6

ER -

Kalkers NF, de Groot V, Lazeron RHC, Killestein J, Adèr HJ, Barkhof F et al. MS functional composite: relation to disease phenotype and disability strata. Neurology. 2000 Mar 28;54(6):1233-1239.